Physical exercise eased signs of a type of iron-mediated cell death called ferroptosis in microglia and improved neurological function in…
Articles by Lindsey Shapiro, PhD
Rare mutations that impair the normal activity of the ITSN1 gene were found to increase the risk of Parkinson’s…
The U.S. Food and Drug Administration (FDA) approved Medtronic’s BrainSense adaptive deep brain stimulation (DBS) system and electrode identifier…
Gene enhancers may play an important role in neuronal development and neurological conditions such as Parkinson’s disease, a study…
Supernus Pharmaceuticals is on track to make Onapgo (apomorphine hydrochloride) — its newly approved medication for treating motor fluctuations…
People with tremor-dominant Parkinson’s disease experience a higher burden of nonmotor symptoms than people with essential tremor (ET),…
The diabetes medication exenatide did not slow motor symptom progression in treated Parkinson’s patients relative to those given…
A study found a link between the likely presence of REM sleep behavior disorder (RBD) in people with Parkinson’s…
The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) for the continuous treatment of motor fluctuations…
Several promising strategies for developing therapeutics capable of crossing or bypassing the blood-brain barrier (BBB) offer potential for treating neurological…